{"id":"https://openalex.org/W47048378","doi":null,"title":"Inhibition of activated blood platelets by interferon alpha 2b in chronic hepatitis C.","display_name":"Inhibition of activated blood platelets by interferon alpha 2b in chronic hepatitis C.","alternate_titles":[],"publication_year":2004,"publication_date":"2004-09-01","ids":{"openalex":"https://openalex.org/W47048378","mag":"47048378","pmid":"https://pubmed.ncbi.nlm.nih.gov/15362767"},"language":"en","primary_location":{"id":"pmid:15362767","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15362767","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepato-gastroenterology","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W47048378"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077813829","display_name":"Anatol Panasiuk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146122375","display_name":"Medical University of Bia\u0142ystok","ror":"https://ror.org/00y4ya841","country_code":"PL","type":"education","lineage":["https://openalex.org/I146122375"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Anatol Panasiuk","raw_affiliation_strings":["Department of Infectious Diseases, Medical University of Bialystok, Bialystok, Poland. apanasiuk@wp.pl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Medical University of Bialystok, Bialystok, Poland. apanasiuk@wp.pl","institution_ids":["https://openalex.org/I146122375"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087014477","display_name":"Danuta Prokopowicz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Danuta Prokopowicz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037502891","display_name":"Janusz \u017bak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janusz Zak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086723945","display_name":"Bozena Panasiuk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bozena Panasiuk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109316234","display_name":"Jolanta Wysocka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jolanta Wysocka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9021,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.72343948,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":92},"biblio":{"volume":"51","issue":"59","first_page":"1417","last_page":"1421"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.7689999938011169,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.7689999938011169,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.22200000286102295,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12352","display_name":"Heparin-Induced Thrombocytopenia and Thrombosis","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interferon-alpha-2b","display_name":"interferon alfa-2b","score":0.9409999847412109},{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.9919999837875366},{"id":"https://openalex.org/keywords/platelet-activation","display_name":"platelet activation","score":0.7580000162124634},{"id":"https://openalex.org/keywords/platelet-morphology","display_name":"platelet morphology","score":0.8980000019073486},{"id":"https://openalex.org/keywords/p-selectin","display_name":"P-selectin","score":0.8569999933242798},{"id":"https://openalex.org/keywords/soluble-p-selectin","display_name":"soluble P-selectin","score":0.8640000224113464},{"id":"https://openalex.org/keywords/platelet-derived-growth-factor","display_name":"platelet-derived growth factor","score":0.8840000033378601},{"id":"https://openalex.org/keywords/thrombopoietin","display_name":"thrombopoietin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9319999814033508},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9950000047683716},{"id":"https://openalex.org/keywords/platelet-receptors","display_name":"platelet receptors","score":0.6859999895095825},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.6759999990463257},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.3449999988079071}],"concepts":[{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.8750258684158325},{"id":"https://openalex.org/C2777863708","wikidata":"https://www.wikidata.org/wiki/Q424519","display_name":"Thrombopoietin","level":4,"score":0.7786240577697754},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.5707815885543823},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5546669363975525},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49732640385627747},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.4793030321598053},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.4767899513244629},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4634532630443573},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.41945961117744446},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3330332338809967},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16275888681411743},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.10793030261993408},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.07632613182067871},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008111","descriptor_name":"Liver Function Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010976","descriptor_name":"Platelet Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010982","descriptor_name":"Platelet-Derived Growth Factor","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010982","descriptor_name":"Platelet-Derived Growth Factor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015539","descriptor_name":"Platelet Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019007","descriptor_name":"P-Selectin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D019007","descriptor_name":"P-Selectin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019038","descriptor_name":"Platelet Glycoprotein GPIb-IX Complex","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019038","descriptor_name":"Platelet Glycoprotein GPIb-IX Complex","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D034061","descriptor_name":"Thrombopoiesis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D040201","descriptor_name":"Platelet Membrane Glycoprotein IIb","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D040201","descriptor_name":"Platelet Membrane Glycoprotein IIb","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:15362767","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15362767","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepato-gastroenterology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2072905632","https://openalex.org/W1976631783","https://openalex.org/W2035453385","https://openalex.org/W2019559792","https://openalex.org/W2144692048","https://openalex.org/W1989138308","https://openalex.org/W2380124178","https://openalex.org/W2051505813","https://openalex.org/W2417283370","https://openalex.org/W2088150811"],"abstract_inverted_index":{"BACKGROUND/AIMS:":[0],"Interferon":[1,161],"alpha":[2,38,121],"used":[3],"in":[4,19,25,45,54,131,146,151,157,173,189,204,209],"treatment":[5,61,81],"of":[6,17,36,79,82,87,99,128,182],"chronic":[7,46,134,190],"hepatitis":[8,47,135,191],"C":[9,136],"significantly":[10,137],"influences":[11],"the":[12,34,76,80,144,149,155,210],"blood":[13,43,88,102,139],"platelets.":[14],"The":[15,50,68,126],"role":[16],"platelets":[18,44,89,140,198],"initiating":[20],"and":[21,74,95,108,117,154,168,199,206],"developing":[22],"pathological":[23],"processes":[24,208],"hepatic":[26],"diseases":[27],"is":[28],"still":[29],"barely":[30],"known.":[31],"We":[32],"studied":[33],"effects":[35,138],"interferon":[37,176],"2b":[39],"(IFN":[40],"alpha2b)":[41],"on":[42,75,101,165],"C.":[48,192],"METHODOLOGY:":[49],"studies":[51],"were":[52,90,122],"conducted":[53],"16":[55],"patients":[56,132],"who":[57],"underwent":[58],"IFN":[59,83,129,194],"alpha2b":[60,130,195],"3":[62],"times":[63],"a":[64],"week":[65],"at":[66],"6MU.":[67],"examination":[69],"was":[70],"carried":[71],"out":[72],"before":[73],"14th":[77],"day":[78],"alpha2b.":[84],"Morphological":[85],"parameters":[86],"determined":[91],"by":[92,142],"hematological":[93],"methods":[94],"flow":[96],"cytometry.":[97],"Expression":[98],"receptors":[100],"platelet":[103,159],"surfaces":[104],"(CD41,":[105],"CD42a,":[106],"CD62P)":[107],"thrombopoietin,":[109,183],"platelet-derived":[110,169],"growth":[111,170],"factor,":[112],"soluble":[113],"form":[114],"sP-selectin,":[115],"IL-6,":[116],"tumor":[118,184],"necrosis":[119,185],"factor":[120,171,186],"also":[123],"determined.":[124],"RESULTS:":[125],"use":[127],"with":[133],"morphology":[141],"causing":[143],"decrease":[145],"their":[147,202],"number,":[148],"change":[150],"population":[152],"size,":[153],"increase":[156,180],"large":[158],"count.":[160],"decreases":[162,201],"P-selectin":[163],"expression":[164],"platelets,":[166],"sP-selectin":[167],"concentration":[172,181],"plasma.":[174],"During":[175],"therapy":[177],"we":[178],"noted":[179],"alpha,":[187],"IL-6":[188],"CONCLUSIONS:":[193],"stabilizes":[196],"activated":[197],"probably":[200],"participation":[203],"inflammatory":[205],"fibrotic":[207],"liver.":[211]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W47048378","counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
